Cellworks Presents Novel Mechanistic Approach to Predicting Drug–Drug Interaction Risk in Oncology at AACR 2026

Clinical Trials, Studies & Reports Scientific Sessions/Conferences April 22, 2026

Cellworks has introduced a novel mechanistic approach to predict drug–drug interaction risk in oncology. This study suggests that biologically grounded predictions could significantly reduce safety-related failures in combination therapies, enhancing drug development and clinical care.

Study suggests biologically grounded predictions could reduce safety-related failures in combination therapies in drug development and clinical care settings

SAN DIEGO, CA, UNITED STATES, April 22, 2026 /⁨EINPresswire.com⁩/ — Cellworks Group Inc., the …